Skip to main content

Table 2 Clinical features and outcome related gender in CM patients

From: Gender-specific contributing risk factors and outcome of female cryptococcal meningoencephalitis patients

  Male (n = 77) Female (n = 31) P
Symptoms
 Headache, no. (%) 57 (74.0) 24 (77.4) 0.713
 Fever, no. (%) 48 (62.3) 19 (61.3) 0.919
 Seizure, no. (%) 5 (6.5) 3 (9.7) 0.687
 Dizziness, no. (%) 1 (1.3) 1 (3.2) 0.494
 Ataxia, no. (%) 3 (3.9) 1 (3.2) 1
 Unconsciousness, no. (%) 11 (14.3) 8 (25.8) 0.155
 Psychosis, no. (%) 2 (2.6) 2 (6.5) 0.577
CSF, mean ± SD
 Ratio of CSF glucose/Blood glucose, mean ± SD 0.30 ± 0.18 0.28 ± 0.18 0.54
 CSF pressure (mmH2O), mean ± SD 266.49 ± 60.13 271.94 ± 49.49 0.66
 CSF glucose (mmol/L), mean ± SD 2.08 ± 1.36 1.64 ± 1.01 0.80
 CSF protein (g/L), mean ± SD 0.94 ± 1.53 0.86 ± 0.51 0.11
Abnormal EEGa, no. (%) 17 (68.0) 10 (76.9) 0.71
Abnormal MRIb, no. (%) 25 (75.8) 9 (60.0) 0.31
Outcome
 Hospitalization length (days), mean ± SD 50.71 ± 55.36 53.35 ± 53.93 0.44
 Survival time (months), mean ± SD 30.40 ± 45.30 21.22 ± 36.15 0.09
 Dead, no. (%) 30 (45.5) 15 (53.6) 0.47
  1. aAbnormal EEG included 5 cases had normal background with focal slow wave and 5 had diffused slow wave in the background
  2. bAbnormal MRI included Bubble sign 5 cases (2 at the basal ganglion and 3 at subcortex), hydrocephalus 5 cases and 6 cases with abnormal cerebral lesions (6 cases with more than one abnormal features)